Synthesis of N-methyl-N-[(1S)-1-[(3R)-pyrrolidin-3-yl]ethyl]amine |
| |
Authors: | Fleck Thomas J McWhorter William W DeKam Richard N Pearlman Bruce A |
| |
Affiliation: | Early Process Research and Development, Medicinal Chemistry Research, and Chemical Research and Development, Pfizer, Inc., Kalamazoo, Michigan 49001, USA. |
| |
Abstract: | N-Methyl-N-[(1S)-1-[(3R)-pyrrolidin-3-yl]ethyl]amine (1)(1) is a key intermediate in the preparation of premafloxacin (2), which was under development as an antibiotic for use against pathogens of veterinary importance. This paper describes the development of a practical, efficient, and stereoselective process for the preparation of 1 from isobutyl (3S)-3-[methyl[(1S)-1-phenylethyl]amino]butanoate (5c). The key steps in the synthetic sequence are an asymmetric Michael addition, which yields 5c, and a stereoselective alkylation, which yields (3S,4S)-3-allyl-1,4-dimethylazetidin-2-one (17). |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|